Daily Brief: 2017.1.30
FDA recommends that consumers dispose of certain homeopathic teething tablets
According to reports, the U.S. Food and Drug Administration (FDA) announced today that its laboratory analysis found inconsistent amounts of the toxic substance, belladonna, in certain homeopathic teething tablets. In some instances, it was documented that the amounts of belladonna far exceeded the amount claimed on the label.
(Sources: FDA, Pharmacy Times)
Belladonna is a plant. The leaf and root of the belladonna plant are used to make medicine. Despite its toxicity, the chemicals atropine and scopolamine, which are derived from belladonna, have important medicinal properties. Atropine is reportedly more effective at relaxing muscle spasms and regulating heart rate. It’s also used to dilate the pupils during an eye exam. Atropine can also be an antidote for insecticides and chemical warfare agents. Scopolamine has many sources, including belladonna, and is more effective at reducing body secretions, such as stomach acid. It can also help motion sickness, via skin patch.
(Sources: Healthline, Medline)
Homeopathic teething products have not been evaluated or approved by the FDA for safety or effectiveness, and the FDA warned against use in September 2016 after adverse events were reported.
(Sources: Forbes, Pharmacy Times)
- The FDA is recommending that consumers dispose of any of Hyland’s homeopathic teething tablets, and to stop using the products
- The FDA advices consumers to seek medical care immediately if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation after use of these products.
- Health care providers are encouraged to report adverse events associated with the use of homeopathic teething products to the FDA’s MedWatch Adverse Event Reporting Program.